Incheon, South Korea Tuesday, June 17, 2025, 16:00 Hrs [IST] ...

The approval of a new presentation enhances treatment flexibility for children with inflammatory diseases.

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® ...

Tthe US Anti-Doping Agency announced on Tuesday the 24-year-old American snowboarder had accepted a three-month suspension ...

The two sisters running Playhouse MD are reimagining children's healthcare through the transformative power of play.

The company has asked users to monitor patients frequently to ensure the appropriate infusion is being delivered.

Baxter’s recall of the system involves updating instructions for use. It does not require removal from use or sale. However, ...

As radiopharmaceutical therapies gain momentum, new challenges are emerging in how they’re administered—especially around ...

Here are seven new shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. Editor’s note: The drugs listed are in alphabe ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...